CME/CE from MPR


MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for myCME.com. See below for a list of each quarter's courses. Click here to visit MPR's website.




Latest Courses

Clinical Review

New Drug Review from MPR (April 2014)

1.00 Credits
Clinical Review

New Drug Review from MPR (October 2013)

1.00 Credits
HM 



Archived CME/CE Courses

HM 


MPR Drug News


Tanzeum Now Available for Type 2 Diabetes

GlaxoSmithKline announced that Tanzeum (albiglutide) subcutaneous injection is now available.

Alirocumab Meets Primary Endpoint in Hypercholesterolemia Trials

Results announced from nine new Phase 3 ODYSSEY trials of alirocumab (Sanofi and Regeneron) in patients with hypercholesterolemia.

FDA Approves New Indication for Eylea

Regeneron announced that the FDA has approved Eylea (aflibercept) injection for the treatment of diabetic macular edema (DME).

Discolored Lidocaine Solution Prompts Recall

Hospira announced a voluntary recall of one lot of Lidocaine HCl Injection, 2% due to a report of discolored solution with visible particles.

Gene Chip Finds New Genetic Risk Factors for Parkinson's Disease

New research has identified over two dozen genetic risk factors involved in Parkinsonism, including six that were previously unknown.